We only have this paper's title and publication details.
Read it at the sourceAnswers are grounded in this paper and cite their sources.
Compares fixed-duration cytarabine consolidation's effectiveness on relapse-free survival in younger AML patients, suggesting it as a better option than indefinite Aza-Ven.
No takes yet. Share an insight, caveat, or question.
Swain et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: